BackNomura Research Institute,Ltd. Overview

Nomura Research Institute,Ltd. Receivables

Track Nomura Research Institute,Ltd.'s receivables ($160B) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Receivables
$161.78B
↓ 14.50% YoYΔ $-27.45B vs prior year quarter

Peer trimmed avg / median

Loading

Nomura Research Institute,Ltd. Receivables History

Loading

Nomura Research Institute,Ltd. vs. peers: Receivables Comparison

Loading

Nomura Research Institute,Ltd. Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Nomura Research Institute,Ltd. (NURAF) FAQ

Nomura Research Institute,Ltd.'s receivables stands at $160B as of June 2026. That compares with $190B in the prior-year period — down 14.5% year over year. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

Nomura Research Institute,Ltd. reported $160B in receivables versus $190B a year earlier — a 14.5% year-over-year decrease. The historical chart on this page makes it easier to see whether that move is part of a longer pattern.

That compares with $190B in the prior-year period — down 14.5% year over year. Sustained growth in receivables can support a stronger franchise, while sharp declines may reflect divestitures, weaker demand, or accounting changes. Always read YoY moves with the footnotes of recent filings in mind.

The history chart shows how Nomura Research Institute,Ltd.'s receivables evolved across reporting periods, while the comparison chart places NURAF next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.

Yes — within Technology, receivables is commonly used to spot outliers. Nomura Research Institute,Ltd.'s reading of $160B is a starting point; confirm whether differences come from growth, margins, accounting choices, or one-time items before treating an outlier as a buy or sell signal.